A Study to Find the Minimum Inhibitory Concentration of KAE609 in Adult Male Patients With P. Falciparum Monoinfection
Clinical trial NCT01836458 · COMPLETED
Trial details
- NCT number
- NCT01836458
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2015-03-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.